Abstract
Scabies is a global problem and a significant source of morbidity in nursing home residents and workers because of its highly contagious nature. It is also a problem in hospitals that care for the elderly, the debilitated, and the immunocompromised. New outbreaks continue to occur, despite controlling the recurrent epidemics. Scabies manifests as papules, pustules, burrows, nodules, and occasionally urticarial papules and plaques. Most of the patients with scabies experience severe pruritus. A subset of patients have crusted or Norwegian scabies. These patients, who are usually debilitated or immunocompromised, do not experience the urge to scratch, and therefore do not scratch their own skin. Diagnosis of scabies is based on patient history, physical examination, and demonstration of mites, eggs, or scybala (black or brown football-shaped masses of feces of scabies) on microscopic examination.
Scabies can be treated with topical or oral therapies. Topical treatments include 5% permethrin cream, 1% lindane (gamma benzene hexachloride) lotion, 6% precipitated sulfur in petrolatum, crotamiton, malathion, allethrin spray, and benzyl benzoate. Ivermectin, the only oral treatment, is not approved for scabies in the US. Most authorities advocate using a scabicide several times, specifically once a week over a period of 2–3 weeks. In an outbreak of scabies in a nursing home, residents, staff, and frequent visitors should all be treated even if they are not symptomatic. Ivermectin is useful in treating patients with Norwegian or crusted scabies, or who are debilitated. Ivermectin has no serious reported adverse effects. Model treatment plans to stop scabies epidemics have been developed. These plans coordinate treatment of all persons exposed (including ivermectin for debilitated patients), isolation of infected patients, disinfection of objects that patients have come into contact with, and education and reassurance of the medical staff. Failure to coordinate notification, education, treatment, and disinfection leads to failure to control scabies epidemics. Control of epidemics of institutional scabies requires attention to treatment effects and logistics. Treatment is low risk, but cumbersome because many individuals need be treated. It is advisable to restrict, where possible, the number of staff members that deal with scabies patients to limit the spread of the scabies. Prolonged surveillance is required for the eradication of institutional scabies. While the foregoing plans require coordination of all involved personnel and sustained efforts, they are necessary to halt the spread of scabies to patients and staff, to enhance their morale, and to prevent deterioration of labor and public relations.
Similar content being viewed by others
References
Problems in nursing homes for the aged. Scabies returns: massively! Krankenpfl J 2002; 40 (1–2): 38–9
Tan HH, Goh CL. Parasitic skin infections in the elderly: recognition and drug treatment. Drugs Aging 2001; 18 (3): 165–76
Chouela E, Abeldano A, Pellerano G, et al. Diagnosis and treatment of scabies: a practical guide. Am J Clin Dermatol 2002; 3: 9–18
Haag ML, Brozena SJ, Fenske NA. Attack of the scabies: what to do when an outbreak occurs. Geriatrics 1993; 48: 45–6, 51–3
Levine N. Scaly, crusted papules: these pruritic lesions can become epidemic in nursing home residents [letter]. Geriatrics 1997; 52: 90
Moberg SA, Lowhagen GB, Hersle KS. An epidemic of scabies with unusual features and treatment resistance in a nursing home. J Am Acad Dermatol 1984; 11: 242–4
Parish LC, Witkowski JA, Millikan LE. Scabies in the extended care facility: revisited. Int J Dermatol 1991; 30: 703–6
Konishi N, Suzuki K, Tokura Y, et al. Bullous eruption associated with scabies: evidence for scabetic induction of true bullous pemphigoid. Acta Derm Venereol 2000; 80 (4): 281–3
Hurwitz S. Scabies in babies. Am J Dis Child 1973; 126 (2): 226–8
Parish LC, Millikan LE, Witkowski JA, et al. Scabies in the extended care facility. Int J Dermatol 1983; 22: 380–2
Wendel K, Rompalo A. Scabies and pediculosis pubis: an update of treatment regimens and general review. Clin Infect Dis 2002; 35 Suppl. 2: S146–51
del Giudice P. Ivermectin in scabies. Curr Opin Infect Dis 2002; 15: 123–6
Elgart ML. A risk-benefit assessment of agents used in the treatment of scabies. Drug Saf 1996; 14 (6): 386–93
Franz TJ, Lehman PA, Franz SF, et al. Comparative percutaneous absorption of lindane and permethrin. Arch Dermatol 1996; 132: 901–5
Solomon BA, Haut SR, Carr EM, et al. Neurotoxic reaction to lindane in an HIV-seropositive patient. An old medication’s new problem. J Fam Pract 1995; 40 (3): 291–6
Buffet M, Dupin N. Current treatments for scabies. Fundam Clin Pharmacol 2003; 17 (2): 217–25
Bigby M. A systematic review of the treatment of scabies. Arch Dermatol 2000; 136: 387–9
Millership S, Readman R, Bracebridge S. Use of ivermectin, given orally, to control scabies in homes for the elderly mentally ill. Commun Dis Public Health 2002; 5: 144–6
Haas N, Henz BM, Ohlendorf D. Is a single oral dose of ivermectin sufficient in crusted scabies? Int J Dermatol 2001; 40: 599–600
Elgart GW, Meinking TL. Ivermectin. Dermatol Clin 2003; 21 (2): 277–82
Yonkosky D, Ladia L, Gackenheimer L, et al. Scabies in nursing homes: an eradication program with permethrin 5% cream. J Am Acad Dermatol 1990; 23: 1133–6
Robles Garcia M, de la Lama Lopez-Areal J, Avellaneda Martinez C, et al. Nosocomial scabies outbreak. Rev Clin Esp 2000; 200: 538–42
Wilson MM, Philpott CD, Breer WA. Atypical presentation of scabies among nursing home residents. J Gerontol A Biol Sci Med Sci 2001; 56: M424–7
Dannaoui E, Kiazand A, Piens M, et al. Use of ivermectin for the management of scabies in a nursing home. Eur J Dermatol 1999; 9: 443–5
Sullivan JR, Watt G, Barker B. Successful use of ivermectin in the treatment of endemic scabies in a nursing home. Australas J Dermatol 1997; 38: 137–40
Estes SA, Estes J. Therapy of scabies: nursing homes, hospitals, and the homeless. Semin Dermatol 1993; 12: 26–33
Paasch U, Haustein UF. Treatment of endemic scabies with allethrin, permethrin and ivermectin: evaluation of a treatment strategy. Hautarzt 2001; 52 (1): 31–7
Paasch U, Haustein UF. Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin. Int J Dermatol 2000; 39: 463–70
Andersen BM, Haugen H, Rasch M, et al. Outbreak of scabies in Norwegian nursing homes and home care patients: control and prevention. J Hosp Infect 2000; 45: 160–4
Xavier G. Public relations. Nurs Times 1998; 94: 74–5
Paules SJ, Levisohn D, Heffron W. Persistent scabies in nursing home patients. J Fam Pract 1993; 37: 82–6
Jack M. Scabies outbreak in an extended care unit: a positive outcome. Can J Infect Control 1993; 8: 11–3
Jimenez-Lucho VE, Fallon F, Caputo C, et al. Role of prolonged surveillance in the eradication of nosocomial scabies in an extended care Veterans Affairs medical center. Am J Infect Control 1995; 23: 44–9
Arlian LG, Estes SA, Vyszenski-Moher DL. Prevalence of Sarcoptes scabiei in the homes and nursing homes of scabietic patients. J Am Acad Dermatol 1988; 19: 806–11
Acknowledgements
No sources of funding were used to assist in the preparation of this manuscript. The author has no conflicts of interest that are directly relevant to the content of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Scheinfeld, N. Controlling Scabies in Institutional Settings. Am J Clin Dermatol 5, 31–37 (2004). https://doi.org/10.2165/00128071-200405010-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128071-200405010-00005